Exile in the Maghreb: Jews under Islam, Sources and Documents, 997–1912. By Paul B. Fenton and David G. Littman. Madison, NJ: FairLeigh Dickinson University Press, 2016. Pp. xxxv + 627. $60, £39.95 ; $57, £39.95.

The Heythrop Journal, Volume 63, Issue 1, Page 144-149, January 2022.

Dr. Zaslavsky has gathered together forty essays that represent the fruits of his lifetime of reading and teaching. The essays exemplify a method of reading substantive works that has been called Talmudic. The essays examine works by Homer, Plato, Aristotle, Moses Maimonides, Kant, DeQuincey, Chaucer, Shakespeare, Donne, Milton, Keats, Poe, Melville, Dickinson, Frost, Sherwood Anderson, Fitzgerald, cummings, Neruda, Arthur Miller, and Faulkner. In addition, there are essays on the Bible, the Constitution, and detective fiction. In every instance, the examined (...) author is treated as a highly deliberate, conscious craftsperson whose intention it is the reader’s task to discern. (shrink)

The question "When are research risks reasonable in relation to anticipated benefits?" is at the heart of disputes in the ethics of clinical research. Institutional review boards are often criticized for inconsistent decision-making, a problem that is compounded by a number of contemporary controversies, including the ethics of research involving placebo controls, developing countries, incapable adults and emergency rooms. If this pressing ethical question is to be addressed in a principled way, then a systematic approach to the ethics of risk (...) in research is required. Component analysis provides such a systematic approach. (shrink)

This volume is a direct result of a conference held at Princeton University to honor George A. Miller, an extraordinary psychologist. A distinguished panel of speakers from various disciplines -- psychology, philosophy, neuroscience and artificial intelligence -- were challenged to respond to Dr. Miller's query: "What has happened to cognition? In other words, what has the past 30 years contributed to our understanding of the mind? Do we really know anything that wasn't already clear to William James?" Each participant tried (...) to stand back a little from his or her most recent work, but to address the general question from his or her particular standpoint. The chapters in the present volume derive from that occasion. (shrink)

Special moral, regulatory, and scientific questions surround the inclusion of children in health-related research. These questions arise from a fundamental moral tension between the obligation to expose children to research participation to ensure that they share in the benefits that arise from it and the obligation to protect them from the harms associated with their inappropriate involvement in research. This tension is felt in the development of moral and regulatory frameworks for the protection of child research subjects and in the (...) implementation and interpretation of these frameworks by institutional review boards. (shrink)

The existing EELS literature has usefully identified the scope of ethical issues posed by pharmacogenetic and pharmacogenomic research. The time has come for in-depth examination of particular ethical issues. The involvement of racial and ethnic communities in pharmacogenetic and pharmacogenomic research is contentious precisely because it touches upon the science and politics of studying racial and ethnic difference. To date, the ethics literature has not seriously taken account of the fact that such research impinges upon the interests of communities, and (...) that taking such interests seriously requires that we both protect and empower communities in research. We propose a framework that rests upon the recognition that communities are heterogeneous human associations and differing policies are appropriate for differing communities. Community consent and consultation and community consultation alone are neither appropriate nor required for all pharmacogenetic and pharmacogenomic research. Rather, application of these policy protections must take into account particulars of both planned research and the communities involved. (shrink)